CTSH
65
-3
JBHT
63
-5
STI
31
19
LNC
45
-4
TXN
49
-6
ZTS
49
2
IVZ
49
-3
DVA
72
-3
AMAT
43
-5
WFC
80
-2
MAT
38
-3
PX
73
-6
SHW
70
2
DUK
50
-2
GILD
56
-4
DE
36
-2
FTI
78
-3
NWS
79
-4
PDCO
30
-6
FDX
54
14
CTSH
65
-3
JBHT
63
-5
STI
31
19
LNC
45
-4
TXN
49
-6
ZTS
49
2
IVZ
49
-3
DVA
72
-3
AMAT
43
-5
WFC
80
-2
MAT
38
-3
PX
73
-6
SHW
70
2
DUK
50
-2
GILD
56
-4
DE
36
-2
FTI
78
-3
NWS
79
-4
PDCO
30
-6
FDX
54
14
Financhill
Back

Prelude Therapeutics Vs. NovaBay Pharmaceuticals Industry Stock Comparison

Sell
19

PRLD
Prelude Therapeutics

Last Price:
1.03
Seasonality Move:
21.44%
Sell
40

NBY
NovaBay Pharmaceuticals

Last Price:
0.73
Seasonality Move:
-7.72%
Sell
19
Prelude Therapeutics (PRLD) is a Sell

Is Prelude Therapeutics a Buy, Sell or Hold?

  • The current Prelude Therapeutics [PRLD] share price is $1.06. The Score for PRLD is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
  • PRLD is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
40
NovaBay Pharmaceuticals (NBY) is a Sell

Is NovaBay Pharmaceuticals a Buy, Sell or Hold?

  • The current NovaBay Pharmaceuticals [NBY] share price is $0.71. The Score for NBY is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
  • NBY is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

PRLD Stock Price Chart

What is Prelude Therapeutics's stock price today?

  • The Prelude Therapeutics share price today is $1.06
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PRLD is experiencing selling pressure, which indicates risk of future bearish movement.

NBY Stock Price Chart

What is NovaBay Pharmaceuticals's stock price today?

  • The NovaBay Pharmaceuticals share price today is $0.71
    The current trend is relatively stagnant and NBY is experiencing selling pressure, which indicates risk of future bearish movement.

PRLD Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.32 Sell
Relative Strength Index (14 RSI): 21.5 Sell
Chaikin Money Flow: -457523 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.21 - 1.83) Sell
Bollinger Bands (100): (1.92 - 5.38) Sell

NBY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.03 Buy
Relative Strength Index (14 RSI): 53.84 Buy
Chaikin Money Flow: -257778 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.59 - 0.73) Buy
Bollinger Bands (100): (0.28 - 1.62) Sell

PRLD Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1.21 Sell
20-day SMA: 1.42 Sell
50-day SMA: 2.27 Sell
200-day SMA: 3.86 Sell
8-day EMA: 1.21 Sell
20-day EMA: 1.44 Sell
50-day EMA: 2.23 Sell
200-day EMA: 3.56 Sell

NBY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.73 Sell
20-day SMA: 0.67 Buy
50-day SMA: 0.63 Buy
200-day SMA: 2.49 Sell
8-day EMA: 0.72 Sell
20-day EMA: 0.69 Buy
50-day EMA: 0.74 Sell
200-day EMA: 5.92 Sell

Prelude Therapeutics Earnings Growth & PRLD Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.25 per share, and an increase next year of $0.31 per share.

NovaBay Pharmaceuticals Earnings Growth & NBY Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $77.59 per share, and an increase next year of $2.44 per share.

Prelude Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

NovaBay Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):